Cancer/Tumor Profiling Market Business Segmentation By Revenue And Structure Forecast
Cancer profiling is a technique used to classify tumors more accurately, which helps in predicting
the patient's clinical outcome. Cancer/Tumor profiling helps in identification of genomic alteration,
which aid to choose a proper therapy for treating cancer. This technique reduces the trial and error
process in diagnosis of cancer at various stages and provide more precise and accurate information
about clinical outcomes of cancer. Different tests are utilized in the diagnosis of cancer such as for
instance laboratory test (blood and urine), biopsy, imaging test (X-ray, MRI, PET/CT, and
ultrasound), nuclear medicine scan, and lumber puncture, which is unable to identify exact reason
for cancer in early stages. This is often resulted in over-treatment of cancer patients.
A number of the major key players operating in the global Cancer/Tumor Profiling Market
include Proteome Sciences PLC, Life Technologies Corporation, Illumina, Inc., BioTheranostics,
RiboMed Biotechnologies Inc., NeoGenomics Laboratories, Oxford Gene Technology Ltd.,
Genomic Health Inc., Agendia, and Oncopath Laboratories.
Read More@ https://bit.ly/3xD8ouc